Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment

Mahshid Sadeghi

doi:doi:10.11648/j.ijmsa.20241303.12

Review Article |

| Peer-Reviewed

Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment

Mahshid Sadeghi^*

Published in International Journal of Materials Science and Applications (Volume 13, Issue 3)

Received: 26 February 2024 Accepted: 21 March 2024 Published: 3 June 2024

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Breast cancer is the most commonly diagnosed form of cancer globally, with women having a higher risk of developing the disease. Current treatment approaches, such as surgery, chemotherapy, and radiotherapy, encounter significant difficulties due to the heterogeneous and intricate regulation of tumors. Nanotechnology, especially the utilization of graphene oxide (GO), presents a promising approach to overcoming the limitations of traditional treatments. GO's unique properties, including its two-dimensional structure, functional groups, and high surface area, make it an ideal material for developing multifunctional nanocarriers. Graphene oxide-based nanocarriers have demonstrated immense potential in breast cancer therapeutics by overcoming the limitations and adverse reactions associated with chemotherapy. The functionalization of GO's surface using biocompatible substances like chitosan and polyethylene glycol improves the cytotoxicity of GO. Enhancing the cytotoxicity also improves the ability to treat tumors that have developed resistance to traditional treatments. These findings demonstrate the promising efficacy of GO-based nanocarriers in treating breast cancer and pave the way for the development of more precise and efficient treatment strategies in the future, potentially improving therapeutic outcomes.

Published in	International Journal of Materials Science and Applications (Volume 13, Issue 3)
DOI	10.11648/j.ijmsa.20241303.12
Page(s)	41-47
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Breast Cancer, Graphene Oxide, Nanocarrier, Drug Delivery

References

[1]	Sung, H., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2021. 71(3): p. 209-249.
[2]	Eketunde, A. O., Diabetes as a risk factor for breast cancer. Cureus, 2020. 12(5).
[3]	Ruiz-Manzano, R. A., et al., Potential novel risk factor for breast cancer: Toxocara canis infection increases tumor size due to modulation of the tumor immune microenvironment. Frontiers in Oncology, 2020. 10: p. 520261.
[4]	Lv, Y., et al., Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Materials Science and Engineering: C, 2016. 59: p. 652-660.
[5]	Gurunathan, S., et al., An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231). International journal of nanomedicine, 2014: p. 1783-1797.
[6]	Cheang, T.-Y., et al., Graphene oxide–hydroxyapatite nanocomposites effectively deliver HSV-TK suicide gene to inhibit human breast cancer growth. Journal of Biomaterials Applications, 2018. 33(2): p. 216-226.
[7]	Crommelin, D., W. Hennink, and G. Storm, Drug targeting systems: fundamentals and applications to parenteral drug delivery. Drug Delivery and Targeting. New York, NY: Taylor and Francis Inc, 2001: p. 119-125.
[8]	Raslan, A., et al., Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. International Journal of Pharmaceutics, 2020. 580: p. 119226.
[9]	Ma, K., et al., PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery. Journal of Drug Targeting, 2021. 29(8): p. 884-891.
[10]	Sardasht, F. G., et al., Breast Cancer Screening Behaviors Based on Health Belief Model. Journal of Holistic Nursing And Midwifery, 2022. 32(2): p. 89-97.
[11]	Lin, R.-H., et al., Application of deep learning to construct breast cancer diagnosis model. Applied Sciences, 2022. 12(4): p. 1957.
[12]	Malhotra, G. K., et al., Histological, molecular and functional subtypes of breast cancers. Cancer biology & therapy, 2010. 10(10): p. 955-960.
[13]	Makki, J., Diversity of breast carcinoma: histological subtypes and clinical relevance. Clinical medicine insights: Pathology, 2015. 8: p. CPath. S31563.
[14]	Obstetricians, A. C. o. and Gynecologists, Hereditary cancer syndromes and risk assessment. Obstet Gynecol, 2019. 134(6): p. e143-9.
[15]	Xia, B., et al., Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Molecular cell, 2006. 22(6): p. 719-729.
[16]	McTiernan, A., Behavioral risk factors in breast cancer: can risk be modified? The oncologist, 2003. 8(4): p. 326-334.
[17]	Shewach, D. S. and R. D. Kuchta, Introduction to cancer chemotherapeutics. Chemical reviews, 2009. 109(7): p. 2859-2861.
[18]	Tran, P., et al., Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment. Journal of Pharmaceutical Investigation, 2020. 50: p. 261-270.
[19]	Singh, S. K., et al., Drug delivery approaches for breast cancer. International journal of nanomedicine, 2017: p. 6205-6218.
[20]	Zuchowska, A., et al., Well-defined graphene oxide as a potential component in lung cancer therapy. Current Cancer Drug Targets, 2020. 20(1): p. 47-58.
[21]	Singh, G., et al., Fabrication of chlorambucil loaded graphene-oxide nanocarrier and its application for improved antitumor activity. Biomedicine & Pharmacotherapy, 2020. 129: p. 110443.
[22]	Zhang, S., et al., Measuring the specific surface area of monolayer graphene oxide in water. Materials Letters, 2020. 261: p. 127098.
[23]	Zhang, Z., H. C. Schniepp, and D. H. Adamson, Characterization of graphene oxide: Variations in reported approaches. Carbon, 2019. 154: p. 510-521.
[24]	Liu, Y., et al., Biocompatible graphene oxide-based glucose biosensors. Langmuir, 2010. 26(9): p. 6158-6160.
[25]	Kazempour, M., et al., Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier. Artificial cells, nanomedicine, and biotechnology, 2019. 47(1): p. 90-94.
[26]	Makvandi, P., et al., A review on advances in graphene-derivative/polysaccharide bionanocomposites: Therapeutics, pharmacogenomics and toxicity. Carbohydrate polymers, 2020. 250: p. 116952.
[27]	Figueroa, T., C. Aguayo, and K. Fernández, Design and characterization of chitosan-graphene oxide nanocomposites for the delivery of proanthocyanidins. International Journal of nanomedicine, 2020: p. 1229-1238.
[28]	Jafari, Z., et al., Potential of graphene oxide as a drug delivery system for Sumatriptan: a detailed density functional theory study. Journal of Biomolecular Structure and Dynamics, 2021. 39(5): p. 1611-1620.
[29]	Smith, A. T., et al., Synthesis, properties, and applications of graphene oxide/reduced graphene oxide and their nanocomposites. Nano Materials Science, 2019. 1(1): p. 31-47.
[30]	Anwar, A., T.-P. Chang, and C.-T. Chen, Graphene oxide synthesis using a top–down approach and discrete characterization techniques: A holistic review. Carbon Letters, 2022. 32(1): p. 1-38.
[31]	Singh, S. K., et al., Size distribution analysis and physical/fluorescence characterization of graphene oxide sheets by flow cytometry. Carbon, 2011. 49(2): p. 684-692.
[32]	Chen, J., et al., Size distribution-controlled preparation of graphene oxide nanosheets with different C/O ratios. Materials Chemistry and Physics, 2013. 139(1): p. 8-11.
[33]	Zheng, J., et al., Graphene-based materials: A new tool to fight against breast cancer. International Journal of Pharmaceutics, 2021. 603: p. 120644.
[34]	Sahne, F., M. Mohammadi, and G. D. Najafpour, Single-layer assembly of multifunctional carboxymethylcellulose on graphene oxide nanoparticles for improving in vivo curcumin delivery into tumor cells. ACS Biomaterials Science & Engineering, 2019. 5(5): p. 2595-2609.
[35]	Wang, Y. and X. Gong, Superhydrophobic coatings with periodic ring structured patterns for self‐cleaning and oil–water separation. Advanced Materials Interfaces, 2017. 4(16): p. 1700190.
[36]	Zhong, L. and X. Gong, Phase separation-induced superhydrophobic polylactic acid films. Soft Matter, 2019. 15(46): p. 9500-9506.
[37]	Grilli, F., P. Hajimohammadi Gohari, and S. Zou, Characteristics of Graphene Oxide for Gene Transfection and Controlled Release in Breast Cancer Cells. International journal of molecular sciences, 2022. 23(12): p. 6802.
[38]	Rana, A., et al., Functionalized graphene oxide based nanocarrier for enhanced cytotoxicity of Juniperus squamata root essential oil against breast cancer cells. Journal of Drug Delivery Science and Technology, 2022. 72: p. 103370.
[39]	Yang, X., et al., Superparamagnetic graphene oxide–Fe 3 O 4 nanoparticles hybrid for controlled targeted drug carriers. Journal of materials chemistry, 2009. 19(18): p. 2710-2714.
[40]	Tiwari, H., et al., Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells. Colloids and surfaces B: biointerfaces, 2019. 178: p. 452-459.
[41]	Matiyani, M., et al., Polymer grafted magnetic graphene oxide as a potential nanocarrier for pH-responsive delivery of sparingly soluble quercetin against breast cancer cells. RSC advances, 2022. 12(5): p. 2574-2588.
[42]	Fong, Y. T., C.-H. Chen, and J.-P. Chen, Intratumoral delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer therapy. Nanomaterials, 2017. 7(11): p. 388.
[43]	Rajaei, M., et al., Chitosan/agarose/graphene oxide nanohydrogel as drug delivery system of 5-fluorouracil in breast cancer therapy. Journal of Drug Delivery Science and Technology, 2023. 82: p. 104307.
[44]	Vinothini, K., et al., Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier. Biomedicine & Pharmacotherapy, 2019. 110: p. 906-917.
[45]	Tiwari, H., et al., Dual Drug Loaded Potassium-Contained Graphene Oxide as a Nanocarrier in Cocktailed Drug Delivery for the Treatment of Human Breast Cancer. Current Drug Delivery, 2023. 20(7): p. 943-950.

Cite This Article

Plain Text BibTeX RIS

APA Style

Sadeghi, M. (2024). Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. International Journal of Materials Science and Applications, 13(3), 41-47. https://doi.org/10.11648/j.ijmsa.20241303.12

Copy | Download

ACS Style

Sadeghi, M. Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. Int. J. Mater. Sci. Appl. 2024, 13(3), 41-47. doi: 10.11648/j.ijmsa.20241303.12

Copy | Download

AMA Style

Sadeghi M. Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. Int J Mater Sci Appl. 2024;13(3):41-47. doi: 10.11648/j.ijmsa.20241303.12

Copy | Download

@article{10.11648/j.ijmsa.20241303.12,
  author = {Mahshid Sadeghi},
  title = {Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment
},
  journal = {International Journal of Materials Science and Applications},
  volume = {13},
  number = {3},
  pages = {41-47},
  doi = {10.11648/j.ijmsa.20241303.12},
  url = {https://doi.org/10.11648/j.ijmsa.20241303.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmsa.20241303.12},
  abstract = {Breast cancer is the most commonly diagnosed form of cancer globally, with women having a higher risk of developing the disease. Current treatment approaches, such as surgery, chemotherapy, and radiotherapy, encounter significant difficulties due to the heterogeneous and intricate regulation of tumors. Nanotechnology, especially the utilization of graphene oxide (GO), presents a promising approach to overcoming the limitations of traditional treatments. GO's unique properties, including its two-dimensional structure, functional groups, and high surface area, make it an ideal material for developing multifunctional nanocarriers. Graphene oxide-based nanocarriers have demonstrated immense potential in breast cancer therapeutics by overcoming the limitations and adverse reactions associated with chemotherapy. The functionalization of GO's surface using biocompatible substances like chitosan and polyethylene glycol improves the cytotoxicity of GO. Enhancing the cytotoxicity also improves the ability to treat tumors that have developed resistance to traditional treatments. These findings demonstrate the promising efficacy of GO-based nanocarriers in treating breast cancer and pave the way for the development of more precise and efficient treatment strategies in the future, potentially improving therapeutic outcomes.
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment

AU  - Mahshid Sadeghi
Y1  - 2024/06/03
PY  - 2024
N1  - https://doi.org/10.11648/j.ijmsa.20241303.12
DO  - 10.11648/j.ijmsa.20241303.12
T2  - International Journal of Materials Science and Applications
JF  - International Journal of Materials Science and Applications
JO  - International Journal of Materials Science and Applications
SP  - 41
EP  - 47
PB  - Science Publishing Group
SN  - 2327-2643
UR  - https://doi.org/10.11648/j.ijmsa.20241303.12
AB  - Breast cancer is the most commonly diagnosed form of cancer globally, with women having a higher risk of developing the disease. Current treatment approaches, such as surgery, chemotherapy, and radiotherapy, encounter significant difficulties due to the heterogeneous and intricate regulation of tumors. Nanotechnology, especially the utilization of graphene oxide (GO), presents a promising approach to overcoming the limitations of traditional treatments. GO's unique properties, including its two-dimensional structure, functional groups, and high surface area, make it an ideal material for developing multifunctional nanocarriers. Graphene oxide-based nanocarriers have demonstrated immense potential in breast cancer therapeutics by overcoming the limitations and adverse reactions associated with chemotherapy. The functionalization of GO's surface using biocompatible substances like chitosan and polyethylene glycol improves the cytotoxicity of GO. Enhancing the cytotoxicity also improves the ability to treat tumors that have developed resistance to traditional treatments. These findings demonstrate the promising efficacy of GO-based nanocarriers in treating breast cancer and pave the way for the development of more precise and efficient treatment strategies in the future, potentially improving therapeutic outcomes.

VL  - 13
IS  - 3
ER  -

Copy | Download

Author Information

Mahshid Sadeghi

Department of Biomedical Engineering, Tarbiat Modaress University, Tehran, Iran

Contact Email

http://orcid.org/0000-0003-2241-9139

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Sadeghi, M. (2024). Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. International Journal of Materials Science and Applications, 13(3), 41-47. https://doi.org/10.11648/j.ijmsa.20241303.12

Copy | Download

ACS Style

Sadeghi, M. Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. Int. J. Mater. Sci. Appl. 2024, 13(3), 41-47. doi: 10.11648/j.ijmsa.20241303.12

Copy | Download

AMA Style

Sadeghi M. Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment. Int J Mater Sci Appl. 2024;13(3):41-47. doi: 10.11648/j.ijmsa.20241303.12

Copy | Download

@article{10.11648/j.ijmsa.20241303.12,
  author = {Mahshid Sadeghi},
  title = {Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment
},
  journal = {International Journal of Materials Science and Applications},
  volume = {13},
  number = {3},
  pages = {41-47},
  doi = {10.11648/j.ijmsa.20241303.12},
  url = {https://doi.org/10.11648/j.ijmsa.20241303.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmsa.20241303.12},
  abstract = {Breast cancer is the most commonly diagnosed form of cancer globally, with women having a higher risk of developing the disease. Current treatment approaches, such as surgery, chemotherapy, and radiotherapy, encounter significant difficulties due to the heterogeneous and intricate regulation of tumors. Nanotechnology, especially the utilization of graphene oxide (GO), presents a promising approach to overcoming the limitations of traditional treatments. GO's unique properties, including its two-dimensional structure, functional groups, and high surface area, make it an ideal material for developing multifunctional nanocarriers. Graphene oxide-based nanocarriers have demonstrated immense potential in breast cancer therapeutics by overcoming the limitations and adverse reactions associated with chemotherapy. The functionalization of GO's surface using biocompatible substances like chitosan and polyethylene glycol improves the cytotoxicity of GO. Enhancing the cytotoxicity also improves the ability to treat tumors that have developed resistance to traditional treatments. These findings demonstrate the promising efficacy of GO-based nanocarriers in treating breast cancer and pave the way for the development of more precise and efficient treatment strategies in the future, potentially improving therapeutic outcomes.
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment

AU  - Mahshid Sadeghi
Y1  - 2024/06/03
PY  - 2024
N1  - https://doi.org/10.11648/j.ijmsa.20241303.12
DO  - 10.11648/j.ijmsa.20241303.12
T2  - International Journal of Materials Science and Applications
JF  - International Journal of Materials Science and Applications
JO  - International Journal of Materials Science and Applications
SP  - 41
EP  - 47
PB  - Science Publishing Group
SN  - 2327-2643
UR  - https://doi.org/10.11648/j.ijmsa.20241303.12
AB  - Breast cancer is the most commonly diagnosed form of cancer globally, with women having a higher risk of developing the disease. Current treatment approaches, such as surgery, chemotherapy, and radiotherapy, encounter significant difficulties due to the heterogeneous and intricate regulation of tumors. Nanotechnology, especially the utilization of graphene oxide (GO), presents a promising approach to overcoming the limitations of traditional treatments. GO's unique properties, including its two-dimensional structure, functional groups, and high surface area, make it an ideal material for developing multifunctional nanocarriers. Graphene oxide-based nanocarriers have demonstrated immense potential in breast cancer therapeutics by overcoming the limitations and adverse reactions associated with chemotherapy. The functionalization of GO's surface using biocompatible substances like chitosan and polyethylene glycol improves the cytotoxicity of GO. Enhancing the cytotoxicity also improves the ability to treat tumors that have developed resistance to traditional treatments. These findings demonstrate the promising efficacy of GO-based nanocarriers in treating breast cancer and pave the way for the development of more precise and efficient treatment strategies in the future, potentially improving therapeutic outcomes.

VL  - 13
IS  - 3
ER  -

Copy | Download